MAP2K7 and cancer: The SASP induced by combining a mitogen-activated protein kinase (MEK) inhibitor with a CDK4/6 inhibitor promoted the elimination of cancer cells by NK cells and CD8+ T cells in Kras-mutant lung and pancreatic cancer models [38,39].